News & Publications

December 3, 2018 Hans Clevers receives Erasmus Medal

We congratulate Hans Clevers for receiving the Erasmus Medal from the Academia Europaea Cardiff Knowledge Hub. The aim of the Academy is to promote European research, advise governments and international organisations in scientific matters, and further interdisciplinary and international research.

Read more

Posted by Tiny Klunder

August 3, 2018 The HUB is going to participate in the Drug Discovery 2018 Conference in London

Dr. Rob Vries, Managing Director at HUB, will be presenting at the  Drug Discovery 2018 conference, organized by the The European Laboratory Research & Innovation Group, to talk about organoids as sophisticated models for studying diseases and as robust emerging tools for precision medicine. This event will be live in London, October 9 & 10 at … Continue reading The HUB is going to participate in the Drug Discovery 2018 Conference in London

Read more

Posted by Tiny Klunder

July 15, 2018 HUB Announces Collaboration with Merck to Develop Organoid Models for Toxicology

Utrecht, Netherlands, June 29, 2018 – HUB today announced a collaboration with Merck that aims to determine the applicability of the HUB Organoids to study and predict nonclinical drug safety. The collaboration between Merck and HUB seeks to study intestinal toxicity using adult stem cell derived Organoids from different species, including human. HUB Organoids are … Continue reading HUB Announces Collaboration with Merck to Develop Organoid Models for Toxicology

Read more

Posted by Tiny Klunder

July 2, 2018 Stem-cell culture moves to the third dimension

Organoids, named “Method of the Year” last year by Nature Methods, are proving their worth in genetic disorders (e.g. CF), cancer research and drug development. Organoids are increasingly being used to study both normal development and the progression of diseases. Organoids are now  featuring together with Organs-On-Chip in this Nature article: Stem-cell culture moves to … Continue reading Stem-cell culture moves to the third dimension

Read more

Posted by Tiny Klunder

June 12, 2018 HUB is going to participate in the upcoming SLAS Europe conference. Come and join us!

If you are at SLAS in Brussels, we would like to make a suggestion for your afternoon program on Wednesday June 27th. In the Silver hall, at 3.40 pm, Dr. Rob Vries will be speaking about Organoids: The Next Generation In Vitro Predictive Patient Model. Key to the development of the Organoid Technology was the … Continue reading HUB is going to participate in the upcoming SLAS Europe conference. Come and join us!

Read more

Posted by Tiny Klunder

May 3, 2018 HUB Announces Collaboration with Pfizer Inc. on Human Gut Organoids for IBD

Utrecht, Netherlands, May 1, 2018 – HUB today announced a collaboration with Pfizer Inc. that aims to develop a Human Gut Organoid Technology Platform to aid in research related to potential treatments for Inflammatory Bowel Disease (IBD). This collaboration between Pfizer and HUB seeks to develop an IBD-specific human gut organoid platform that, if successful, … Continue reading HUB Announces Collaboration with Pfizer Inc. on Human Gut Organoids for IBD

Read more

Posted by Tiny Klunder

February 5, 2018 MDI Biological Laboratory Launches New Biomedical Innovation Course on Organoid Technology

HUB and MDI Biological Laboratory have announced that they will offer a one-week intensive course, May 27–June 2 2018 (Bar Harbor, Maine, USA) entitled “Applications of Organoid Technology”, Join this unique opportunity and apply if you are curious to work with Organoids, want to learn all about Organoids and the most recent developments in the … Continue reading MDI Biological Laboratory Launches New Biomedical Innovation Course on Organoid Technology

Read more

Posted by Tiny Klunder

January 26, 2018 HUB Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Utrecht, 8 January 2018 – In a study published in Cell, Dr. Hans Clevers, CSO of HUB, has demonstrated that the heterogeneity of breast cancer subtypes can be captured using patient derived Organoid cultures. This new Organoid cancer model system can strongly support effective drug development and facilitates the link between clinical and laboratory data. … Continue reading HUB Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Read more

Posted by Tiny Klunder